Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2019

Mar 19, 2019

33090_dirs_2019-03-19_8ff483ae-a382-4cd5-9dc7-aca215b216ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-03-15

Reporting Person: AWM Investment Company, Inc. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-15 Common Stock S 13637 $15 Disposed 1354288 Indirect
2019-03-18 Common Stock S 7760 $15.1486 Disposed 1346528 Indirect

Footnotes

F1: This is a weighted average price.

F2: AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (CAYMAN) and Special Situations Private Equity Fund, L.P. (PE together with QP and CAYMAN the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 799,427 of Common Stock of the Issuer (the Shares) held by QP, 298,979 Shares held by CAYMAN and 248,122 Shares held by PE.

F3: Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM.
The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not
be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the
Securities Exchange Act of 1934, as amended, or for any other purpose.

F4: These shares reflect the 1 for 3 reverse split effective 5/14/2018.